|
|
Article: Dynavax Appoints Francis R. Cano, Ph.D. to Board of Directors.
- Article from:
- Business Wire
- Article date:
- November 5, 2009
CopyrightCOPYRIGHT 2009 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
BERKELEY, Calif. -- Dynavax Technologies Corporation (Nasdaq:DVAX) announced today that Francis R. Cano, Ph.D. has been appointed to Dynavax's Board of Directors effective November 3, 2009.
"A recognized scientific leader in vaccines and infectious diseases, Francis brings unique expertise and broad experience in research, development, and commercialization to Dynavax," commented Arnold L. Oronsky, Ph.D., Chairman of the Board of Directors of Dynavax. "Francis will provide valuable perspective as Dynavax advances its plans for its Phase 3 hepatitis B vaccine and pipeline products."
Dr. Cano is President and Founder of Cano Biotech Corp., a consulting ...